GURUFOCUS.COM » STOCK LIST » Utilities » Utilities - Independent Power Producers » Orion Pharma Ltd (DHA:ORIONPHARM) » Definitions » EV-to-FCF

Orion Pharma (DHA:ORIONPHARM) EV-to-FCF : -429.82 (As of Mar. 31, 2025)


View and export this data going back to 2013. Start your Free Trial

What is Orion Pharma EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Orion Pharma's Enterprise Value is BDT32,211 Mil. Orion Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was BDT-75 Mil. Therefore, Orion Pharma's EV-to-FCF for today is -429.82.

The historical rank and industry rank for Orion Pharma's EV-to-FCF or its related term are showing as below:

DHA:ORIONPHARM' s EV-to-FCF Range Over the Past 10 Years
Min: -620.4   Med: -26.19   Max: 409.69
Current: -429.82

During the past 12 years, the highest EV-to-FCF of Orion Pharma was 409.69. The lowest was -620.40. And the median was -26.19.

DHA:ORIONPHARM's EV-to-FCF is ranked worse than
100% of 225 companies
in the Utilities - Independent Power Producers industry
Industry Median: 14.18 vs DHA:ORIONPHARM: -429.82

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-31), Orion Pharma's stock price is BDT32.20. Orion Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was BDT-0.071. Therefore, Orion Pharma's PE Ratio (TTM) for today is At Loss.


Orion Pharma EV-to-FCF Historical Data

The historical data trend for Orion Pharma's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Pharma EV-to-FCF Chart

Orion Pharma Annual Data
Trend Dec14 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 70.01 -18.06 -26.93 -30.64 -138.49

Orion Pharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.11 -33.00 -138.49 -49.92 -447.61

Competitive Comparison of Orion Pharma's EV-to-FCF

For the Utilities - Independent Power Producers subindustry, Orion Pharma's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orion Pharma's EV-to-FCF Distribution in the Utilities - Independent Power Producers Industry

For the Utilities - Independent Power Producers industry and Utilities sector, Orion Pharma's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Orion Pharma's EV-to-FCF falls into.


;
;

Orion Pharma EV-to-FCF Calculation

Orion Pharma's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=32211.354/-74.942
=-429.82

Orion Pharma's current Enterprise Value is BDT32,211 Mil.
Orion Pharma's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-75 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orion Pharma  (DHA:ORIONPHARM) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Orion Pharma's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=32.20/-0.071
=At Loss

Orion Pharma's share price for today is BDT32.20.
Orion Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT-0.071.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Orion Pharma EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Orion Pharma's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Orion Pharma Business Description

Traded in Other Exchanges
N/A
Address
153-154 Tejgaon Industrial Area, Orion House, Dhaka, BGD, 1208
Orion Pharma Ltd is a pharmaceutical company engaged in the manufacturing and marketing of pharmaceutical drugs and medicines. It provides its drugs in various dosage forms including tablet, capsule, syrup, suspension, injection, dry powder for syrup and suspension, for therapeutic groups like anticancer, antibiotics, antidiabetics, anxiolytics, diuretics, cardiovascular drugs, and others. In addition, the company is also involved in power generation activities. It generates maximum revenue from power generation activities. The group principally carries out its business operations and markets its products in Bangladesh.

Orion Pharma Headlines

No Headlines